JZ
Zafra Tanaka, Jessica
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Patient relevant outcomes for type 1 diabetes management : A qualitative evidence synthesis | Diabetic medicine |  | 2025 | 38 | 0 | ||
| The Lancet Diabetes & Endocrinology Commission on type 1 diabetes : looking back to move forward | The Lancet. Diabetes & endocrinology | | 2024 | 47 | 0 | ||
| Using a co-creation approach to develop a Core Outcome Set for Type 1 Diabetes Mellitus |  | 2024 | 215 | 196 | |||
| Involving different stakeholders in prioritising outcomes to assess healthcare systems response for type 1 diabetes management : Using co-creation approaches in Peru | The International journal of health planning and management | | 2024 | 46 | 224 | ||
| Outcomes measured in studies assessing health systems interventions for type 1 diabetes management : A scoping review | Diabetic medicine | | 2024 | 59 | 120 | ||
| Using government data to understand the use and availability of medicines for hypertension and diabetes: lessons from Peru | Journal of pharmaceutical policy and practice | | 2022 | 99 | 140 | ||
| Management of type 1 diabetes in low‐ and middle‐income countries: Comparative health system assessments in Kyrgyzstan, Mali, Peru and Tanzania | Diabetic medicine | | 2022 | 234 | 206 | ||
| COVID‐19's impact on type 1 diabetes management : A mixed‐methods study exploring the Peruvian experience | The International journal of health planning and management | | 2022 | 46 | 241 | ||
| Diabetes and the WHO Model List of Essential Medicines | The Lancet. Diabetes & endocrinology | | 2022 | 174 | 0 | ||
| Health system responses for type 1 diabetes: A scoping review | Diabetic medicine | | 2022 | 230 | 600 |
